Univar competitors

Seifi Ghasemi serves as Chairman of the Board, Chief Executive Officer of Rockwood Holdings Inc. He has been Chairman and Chief Executive Officer of Rockwood and subsidiary, Rockwood Specialties Group, Inc., since November 2001. From 1997 to 2001 he was with GKN, plc, a $6.0 billion revenue per year global industrial company. He served as a director of the Main Board of GKN, plc and was Chairman and Chief Executive Officer of GKN Sinter Metals, Inc. and Hoeganes Corporation. Before that, for 18 years, Ghasemi was with BOC Group, plc, a $7.0 billion revenue per year global industrial gas company, which is now part of Linde AG. He was a director of the Main Board of BOC Group, plc, President, BOC Gases Americas and Chairman and Chief Executive Officer of BOC Process Plants, Ltd. and Cryostar. Ghasemi also serves on the board of directors of EnerSys and serves as Chairman of the Electrification Coalition, a nonpartisan, not-for-profit group of business leaders committed to reducing oil dependence through the deployment of electric vehicles on a mass scale. Ghasemi has a Master of Science degree in Mechanical Engineering from Stanford University.

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Guillermo Novo is a Chairman/CEO at ASHLAND GLOBAL HOLDINGS INC and VP:DOW Polyurethanes at Dow Chemical Co. He has worked as Board Member at VERSUM MATERIALS, INC.; Senior VP/Gen Mgr:Electronics at AIR PRODUCTS & CHEMICALS INC /DE/; and Exec VP:Materials Technology at AIR PRODUCTS & CHEMICALS INC /DE/. Guillermo works or has worked as President at United Way in Brazil, MEMBER at United Way of Southeastern Pennsylvania, and Country Manager:Indonesia at Rohm And Haas Co.. He attended University of Michigan and UCF.

Lori J. Ryerkerk is the Chairman, Chief Executive Officer and President of Celanese Corporation, a Fortune 500 global chemical and specialty materials company based in Dallas, Texas. Celanese is a leader in the development and production of materials used in most major industrial and consumer applications. Ryerkerk was named as CEO, as well as a member of the board of directors, in May 2019. She was appointed Chairman in April 2020. Previously, Ryerkerk was the Executive Vice President of Global Manufacturing, the largest business in Shell Downstream Inc. She led a team of 30,000 employees and contractors at refineries and chemical sites worldwide. Ryerkerk’s expertise in the energy industry spans three-plus decades. She combines deep technical and commercial skills with a passion for the manufacturing business. Her unwavering focus on safety, environmental and social performance is the foundation on which she has overseen some of the most technically complex operations in the industry. Ryerkerk joined Shell in May 2010 as the Regional Vice President of Manufacturing in Europe and Africa, and was responsible for the operation of five Shell Manufacturing facilities and five joint ventures. During that time, she improved operational performance of all assets in the region. In October 2013, she was named Executive Vice President of Global Manufacturing, Shell Downstream Inc. Before joining Shell, she was Senior Vice President, Refining, Supply and Terminals at Hess Corporation, where she was responsible for two refineries, 21 terminals (and distribution network) and supply and trading. Prior to that, Ryerkerk spent 24 years with ExxonMobil where she started her career as a process technologist at a refinery in Baton Rouge, Louisiana. Throughout her tenure at ExxonMobil, she took on a variety of operational and senior leadership roles in Refining and Chemicals Manufacturing, Power Generation, and various other groups including Supply, Economics and Planning, HSSE, and Public Affairs/Government Relations. Those assignments took her across the globe, from the U.S. to Europe to Asia. Ryerkerk is a graduate of Iowa State University, where she completed her Chemical Engineering degree. She currently serves on the board of directors of Eaton Corporation, a leading provider of power management technologies and services; and previously she served on the board of Axalta Coating Systems, a leading provider of liquid and powder coatings. Additionally, she actively supports a variety of organizations in her hometown of Beaumont, Texas.

Mr. Farrell has been our Chief Executive Officer since January 2016. From November 2014 through December 2015 Mr. Farrell had been our Chief Financial Officer and Chief Operating Officer. From May 2007 through October 2014, Mr. Farrell had been our Executive Vice President and Chief Financial Officer, and from September 2006 through May 2007, he was our Vice President and Chief Financial Officer. Mr. Farrell was Executive Vice President and Chief Financial Officer of Alpharma Inc. from April 2002 through August 2006. From July 2000 through April 2002, he served as Vice President, Investor Relations & Communications at Ingersoll-Rand Ltd. From November 1994 through June 2000, he held various senior financial positions at AlliedSignal Inc. Mr. Farrell currently serves as a member of the board of directors of Lydall, Inc., a supplier of engineered thermal, acoustical and filtration products.

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Kevin serves as the fifth Chairman and CEO at Stryker since it was founded in 1941 by Dr. Homer Stryker, an orthopaedic surgeon. Stryker is a leading medical technology company with over 40,000 employees. Kevin was born in India, grew up in Canada, and has lived and worked in four countries and four industries. He is the current chair of AdvaMed (Med-Tech trade association) and is a member of the Business Roundtable and Business Council. He is also active with community boards.